Industry News
Pharmaceutical Industry News
Shortly after acquiring Elektrofi…
Shortly after acquiring Elektrofi to beef up its subcutaneous drug delivery offerings, Halozyme Therapeutics has struck another deal to purchase Surf Bio.
With a third consecutive year of…
With a third consecutive year of sales growth under its belt, the company is expecting flat or slightly down revenues in 2026, it said.
Ro is bringing Serena Williams to…
Ro is bringing Serena Williams to the Super Bowl. Months after partnering with Williams, Ro has secured airtime at Super Bowl LX to showcase how the 23-time Grand Slam tennis champion’s life changed after taking
With Cellares preparing to begin…
With Cellares preparing to begin commercial-stage production in 2027, the California-based cell therapy contract manufacturer has taken a major step toward that goal, raising $257 million in a series D round.
Biosynthesis specialist Antheia…
Biosynthesis specialist Antheia has topped off its series C funding with a second close, adding $24 million more to its haul. The financing lift brings Antheia's total funding over the past year to more than
A new FDA nod for autologous stem…
A new FDA nod for autologous stem cell transplant-ineligible patients fortifies Darzalex Faspro's position for patients with newly diagnosed multiple myeloma.
Even as the Trump administration…
Even as the Trump administration works to implement its most-favored-nation pricing system, the U.S. government continues to advance efforts to negotiate Medicare drug prices as enabled by the Inflation Reduction Act.
Boehringer Ingelheim’s mission…
Boehringer Ingelheim’s mission for Super Bowl LX viewers, should they choose to accept it, is to learn more about urine albumin-to-creatinine ratio screening to monitor kidney health in people with certain risk factors.
Outcomes for HER2+ metastatic…
Outcomes for HER2+ metastatic gastroesophageal adenocarcinoma remain poor, underscoring the need for more durable first-line options.
China’s National Medical…
China’s National Medical Products Administration suspended the import, sale and use of Sun's rivastigmine hydrogen tartrate capsules after a virtual site inspection uncovered manufacturing shortfalls.
Nearly two decades after the…
Nearly two decades after the parties first floated the idea of a free trade agreement, the turbulence of the global market has prompted the European Union and India to carry their deal across the finish
After posting 16.2% revenue growth…
After posting 16.2% revenue growth in the last financial year, Servier President Olivier Laureau said the company has moved “one important step closer” to achieving an ambitious goal for 2030.
Pfizer again heads up a physician…
Pfizer again heads up a physician ranking of vaccine manufacturers, beating Merck & Co. and Moderna to complete an unchanged top three from the last edition of the survey. But while the rankings held steady,
Siegfried has signed agreements to…
Siegfried has signed agreements to acquire the controlled drug substance businesses of the Noramco Group and Extractas Bioscience. With the deals, Siegfried gains API sites in Wilmington, Delaware; Athens, Georgia; and Australia.
Following in the footsteps of…
Following in the footsteps of Phathom Pharmaceuticals' and Allergan Aesthetics’ own partnerships with “Saturday Night Live” stars, Teva Pharmaceuticals is turning to a famous funnyman to tackle a not-so-funny topic.
Large drugmakers are facing…
Large drugmakers are facing tighter constraints than in the past, as financial, scientific and reputational pressures converge. According to senior leaders at Bayer and Bristol Myers Squibb, those forces are reshaping pipeline decisions, capital allocation
Catalent made a series of deals…
Catalent made a series of deals early this decade to build up its presence in Gosselies. Now, it's planning to wind down cell therapy manufacturing operations in the town.
The companies had committed to a…
The companies had committed to a five-year partnership in July 2024, in which Kowa agreed to promote the topical treatment to primary care physicians to extend the med's reach beyond dermatologists.
With Enhertu and Datroway, Daiichi…
With Enhertu and Datroway, Daiichi Sankyo has made itself a top-tier player in antibody-drug conjugates. But the road to market leadership is growing more complex as the two AstraZeneca-partnered brands move into earlier lines of
Juggling a mix of customer demand…
Juggling a mix of customer demand and new regulations, Recipharm has built out a new facility in Bengaluru, India, to produce nonbacterial beta-lactam tablets. By commissioning the plant, Recipharm says it has lassoed up a